Thomas Kimber

3.1k total citations
28 papers, 591 citations indexed

About

Thomas Kimber is a scholar working on Neurology, Surgery and Epidemiology. According to data from OpenAlex, Thomas Kimber has authored 28 papers receiving a total of 591 indexed citations (citations by other indexed papers that have themselves been cited), including 23 papers in Neurology, 5 papers in Surgery and 4 papers in Epidemiology. Recurrent topics in Thomas Kimber's work include Parkinson's Disease Mechanisms and Treatments (18 papers), Neurological disorders and treatments (14 papers) and Botulinum Toxin and Related Neurological Disorders (6 papers). Thomas Kimber is often cited by papers focused on Parkinson's Disease Mechanisms and Treatments (18 papers), Neurological disorders and treatments (14 papers) and Botulinum Toxin and Related Neurological Disorders (6 papers). Thomas Kimber collaborates with scholars based in Australia, United States and United Kingdom. Thomas Kimber's co-authors include Philip D. Thompson, Kenneth Butcher, John D. O’Sullivan, P. Alan Barber, Stephen M. Davis, Geoffrey A. Donnan, Christopher Levi, John Fink, David Schultz and Mark Parsons and has published in prestigious journals such as Brain, Neurology and Stroke.

In The Last Decade

Thomas Kimber

24 papers receiving 575 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Thomas Kimber Australia 12 348 247 139 110 80 28 591
Davide Cerone Italy 13 210 0.6× 165 0.7× 95 0.7× 61 0.6× 58 0.7× 17 574
Giovanni Orlandi Italy 16 275 0.8× 225 0.9× 309 2.2× 55 0.5× 33 0.4× 39 617
Frédéric Bourdain France 14 573 1.6× 269 1.1× 173 1.2× 68 0.6× 201 2.5× 35 902
Christoph Schmidauer Austria 15 531 1.5× 397 1.6× 359 2.6× 30 0.3× 75 0.9× 30 927
Sudha R. Gupta United States 8 150 0.4× 127 0.5× 116 0.8× 50 0.5× 40 0.5× 21 538
Tarik Slaoui France 9 379 1.1× 392 1.6× 228 1.6× 27 0.2× 82 1.0× 11 720
E. B. Ringelstein Germany 10 175 0.5× 115 0.5× 92 0.7× 117 1.1× 46 0.6× 30 473
M. Pasquini France 12 213 0.6× 284 1.1× 170 1.2× 41 0.4× 19 0.2× 21 635
Mohamed Al‐Khaled Germany 11 148 0.4× 227 0.9× 149 1.1× 38 0.3× 19 0.2× 34 397
Wansi Zhong China 11 108 0.3× 174 0.7× 62 0.4× 71 0.6× 91 1.1× 43 332

Countries citing papers authored by Thomas Kimber

Since Specialization
Citations

This map shows the geographic impact of Thomas Kimber's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Thomas Kimber with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Thomas Kimber more than expected).

Fields of papers citing papers by Thomas Kimber

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Thomas Kimber. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Thomas Kimber. The network helps show where Thomas Kimber may publish in the future.

Co-authorship network of co-authors of Thomas Kimber

This figure shows the co-authorship network connecting the top 25 collaborators of Thomas Kimber. A scholar is included among the top collaborators of Thomas Kimber based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Thomas Kimber. Thomas Kimber is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Bryant, Robert V., Sarah Haylock‐Jacobs, Alice S. Day, et al.. (2025). Faecal microbiota transplant in Parkinson’s disease: pilot study to establish safety & tolerability. npj Parkinson s Disease. 11(1). 203–203. 3 indexed citations
2.
3.
4.
Kern, Drew S., Khashayar Dashtipour, Jason Aldred, et al.. (2023). Safety of Foslevodopa/Foscarbidopa During Optimization and Maintenance Treatment: Post Hoc Analysis of a Phase 3 Trial (S32.004). Neurology. 100(17_supplement_2).
5.
Soileau, Michael J., Jason Aldred, Nahome Fisseha, et al.. (2022). Safety and efficacy of continuous subcutaneous foslevodopa-foscarbidopa in patients with advanced Parkinson's disease: a randomised, double-blind, active-controlled, phase 3 trial. The Lancet Neurology. 21(12). 1099–1109. 93 indexed citations
6.
Vivash, Lucy, Kelly Bertram, Charles B. Malpas, et al.. (2021). Sodium selenate as a disease-modifying treatment for progressive supranuclear palsy: protocol for a phase 2, randomised, double-blind, placebo-controlled trial. BMJ Open. 11(12). e055019–e055019. 6 indexed citations
7.
Kimber, Thomas. (2021). Approach to the patient with early Parkinson disease: diagnosis and management. Internal Medicine Journal. 51(1). 20–26. 4 indexed citations
8.
Trahair, Laurence G., et al.. (2016). Gastric emptying, postprandial blood pressure, glycaemia and splanchnic flow in Parkinson’s disease. World Journal of Gastroenterology. 22(20). 4860–4860. 13 indexed citations
9.
Thompson, Philip D., et al.. (2015). Fashion victim: rhabdomyolysis and bilateral peroneal and tibial neuropathies as a result of squatting in ‘skinny jeans’. Journal of Neurology Neurosurgery & Psychiatry. 87(7). 782–782. 4 indexed citations
10.
Kimber, Thomas, et al.. (2011). High-Frequency Pallidal Stimulation for Camptocormia in Parkinson Disease: Case Report. Neurosurgery. 68(5). E1501–E1505. 18 indexed citations
11.
Hayes, Michael W., Victor S.C. Fung, Thomas Kimber, & John D. O’Sullivan. (2010). Current concepts in the management of Parkinson disease. The Medical Journal of Australia. 192(3). 144–149. 30 indexed citations
12.
Nagakane, Yoshinari, Søren Christensen, Caspar Brekenfeld, et al.. (2010). EPITHET. Stroke. 42(1). 59–64. 75 indexed citations
13.
Kleinig, Timothy, Thomas Kimber, & Philip D. Thompson. (2009). Stroke prevention and stroke thrombolysis: quantifying the potential benefits of best practice therapies. The Medical Journal of Australia. 190(12). 678–682. 2 indexed citations
14.
Kimber, Thomas, Philip D. Thompson, & Michelle Kiley. (2007). Resolution of dopamine dysregulation syndrome following cessation of dopamine agonist therapy in Parkinson’s disease. Journal of Clinical Neuroscience. 15(2). 205–208. 17 indexed citations
15.
16.
Butcher, Kenneth, Lachlan MacGregor, MW Parsons, et al.. (2004). Multiple definitions of PWI-DWI mismatch reliably predict infarct growth. Stroke. 35(6). 2 indexed citations
17.
Kimber, Thomas, Richard W. Orrell, R. H. M. King, & Lionel Ginsberg. (2003). Pathological findings in a patient with ventilatory failure and chronic inflammatory demyelinating polyneuropathy. Journal of the Peripheral Nervous System. 8(1). 13–16. 10 indexed citations
18.
Kimber, Thomas, Brian P. Brophy, & Philip D. Thompson. (2003). Ataxic arm movements after thalamotomy for Parkinsonian tremor. Journal of Neurology Neurosurgery & Psychiatry. 74(2). 258–259. 3 indexed citations
19.
Kimber, Thomas & Philip D. Thompson. (2000). Increased blink rate in advanced Parkinson's disease: A form of ?off?-period dystonia?. Movement Disorders. 15(5). 982–985. 32 indexed citations
20.
Kimber, Thomas. (1999). Voluntary movement after pallidotomy in severe Parkinson's disease. Brain. 122(5). 895–906. 33 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Davide Cerone Breakdown of academic impact, for papers by Giovanni Orlandi Breakdown of academic impact, for papers by Frédéric Bourdain Breakdown of academic impact, for papers by Christoph Schmidauer Breakdown of academic impact, for papers by Sudha R. Gupta Breakdown of academic impact, for papers by Tarik Slaoui Breakdown of academic impact, for papers by E. B. Ringelstein Breakdown of academic impact, for papers by M. Pasquini Breakdown of academic impact, for papers by Mohamed Al‐Khaled Breakdown of academic impact, for papers by Wansi Zhong
Rankless by CCL
2026